The future of weight loss pharmacotherapy Ozempic and retatrutide represent two points on a trajectory that is moving fast
So if we could inject people with GLP-1, this could be an incredible treatment for diabetes
doi: 10.3389/fmolb.2026.1804435 Received 05 February 2026 Revised 02 March 2026 Accepted 03 March 2026 Published 23 March 2026 Volume 13 - 2026 Edited by Claudia Fiorillo, University of Florence, Italy Reviewed by Gloria Riitano, Sapienza University of Rome, Italy Sanjit Roy, Glycomontra, Inc., United States Updates Copyright 2026 Shi, Qi, Xue, Zhang, Mu, Wang, Zhu, Kong and Han
Reductions in the mitochondrial enzyme -ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental
Tao WH, Shan XS, Zhang JX, Liu HY, Wang BY, Wei X, et al